Chemical Compound

(3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-amino-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one (non-preferred name)

CAS Registry Number 26116-56-3
(3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-amino-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one (non-preferred name) 结构式
Primary record

(3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-amino-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one (non-preferred name)

库存
2,442 克
纯度
98.3 %
CAS
26116-56-3

化合物标识与属性

CAS
26116-56-3
PubChem CID
83952
SMILES
CC[C@@H]1[C@@]([C@@H]([C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)N)C)O)(C)O
Canonical SMILES
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](N)[C@H](C)[C@@H](O)[C@]1(C)O

名称与同义词

  • Erythromycylamine
  • (9S)-9-Amino-9-deoxoerythromycin
  • 9(S)-Erythromycylamine
  • 9-Epierythromycylamine
  • 26116-56-3
  • (9S)-erythromycyclamine
  • Epierythromycyl-A-amine
  • YX9KV1OMA4
  • (9S)-Erythromycylamine A
  • Dirithromycin EP Impurity A
  • RefChem:405596
  • UNII-YX9KV1OMA4
  • 9-Amino-9-deoxoerythromycin
  • GlyTouCan:G22320IE
  • erythromyclamine, (9S)-
  • Erythromycylamine-13C-D3
  • (9S)-9-amino-9-deoxyerythromycin
  • BRN 4241492
  • AC1Q6O1L
  • CHEMBL290242
  • BRL-42852ER
  • MFCD00872156
  • AC1L36I4
  • E.M.A.
  • SCHEMBL13681694
  • BRL 42852ER
  • CHEBI:73708
  • DTXSID00180750
  • Erythromycin, 9-amino-9-deoxo-, (9S)-
  • XCLJRCAJSCMIND-JCTYMORFSA-N
  • (9S)-9-Deoxy-9-aminoerythromycin A
  • KST-1A3328
  • C37H70N2O12
  • CID83952
  • EX-A5468
  • G22320IE
  • 9-Amino-9-deoxo-erythromycin, stereoisomer
  • AR-1A7383
  • BBF-04636
  • BDBM50417963
  • ZINC94303289
  • AKOS037651084
  • AE22802
  • C37-H70-N2-O12
  • HY-W055872
  • LY-024410
  • AC-28327
  • CS-15835
  • Erythromycin, 9-amino-9-deoxo-, stereoisomer
  • LS-64650
  • LY-24410
  • EC 406-790-7
  • LY 024410
  • CS-0047729
  • Erythromycin, 9-amino-9-deoxo-, (9S)- (9CI)
  • D95598
  • A902229
  • Q27144058
  • (3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-amino-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one
  • N0001-017355
  • (3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-amino-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
  • }-3,5,7,9,11,13-HEXAMETHYLOXACYCLOTETRADECAN-2-ONE
  • 26961-95-5
  • (3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-amino-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
  • (3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-AMINO-6-{[(2S,3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLOXAN-2-YL]OXY}-14-ETHYL-7,12,13-TRIHYDROXY-4-{[(2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6-DIMETHYLOXAN-2-YL]OXY}-3,5,7,9,11,13-HEXAMETHYL-1-OXACYCLOTETRADECAN-2-ONE
  • (3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-AMINO-6-{[(2S,3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PY
  • (3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-AMINO-6-{[(2S,3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PY RAN-2-YL]OXY}-14-ETHYL-7,12,13-TRIHYDROXY-4-{[(2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6-DIMETHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY }-3,5,7,9,11,13-HEXAMETHYLOXACYCLOTETRADECAN-2-ONE
  • (3R,4S,5S,6R,7R,9R,10S,11S,12R,13S,14R)-10-amino-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one (non-preferred name)
  • (9S)-9-Amino-9-deoxoerythromycin; (9S)-9-Deoxy-9-aminoerythromycin A; (9S)-Erythromycylamine A; 9(S)-Erythromycylamine; BRL 42852ER; LY 024410; Dirithromycin EP Impurity A
  • 406-790-7
  • ERN
  • RAN-2-YL]OXY}-14-ETHYL-7,12,13-TRIHYDROXY-4-{[(2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6-DIMETHYLTETRAHYDRO-2H-PYRAN-2-YL]OXY